Scientific Standards for Studies on Modified Risk Tobacco Products (2012)

Chapter: Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*

Previous Chapter: Appendix A: Section 911 of the Family Smoking Prevention and Tobacco Control Act of 2009
Suggested Citation: "Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press. doi: 10.17226/13294.

Appendix B

Chapters 1 and 2 from
Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease
1

_______________

1 Institute of Medicine. 2010. Evaluation of biomarkers and surrogate endpoints in chronic disease. Washington, DC: The National Academies Press

Suggested Citation: "Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press. doi: 10.17226/13294.

This page intentionally left blank.

Suggested Citation: "Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press. doi: 10.17226/13294.
Page 257
Suggested Citation: "Appendix B: Chapters 1 and 2 from *Evaluation of Biomarkers andSurrogate Endpoints in Chronic Disease*." Institute of Medicine. 2012. Scientific Standards for Studies on Modified Risk Tobacco Products. Washington, DC: The National Academies Press. doi: 10.17226/13294.
Page 258
Next Chapter: [Appendix B] 1 Introduction
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.